Jul 31,2020

Digital therapy for insomnia could save NHS millions and improve anxiety and depression symptoms

New report finds use of Sleepio delivers high recovery rates, improve mental health outcomes & could save the NHS £56 million over three years. Patients living with the condition who used Sleepio – a digital sleep improvement programme featuring CBT techniques – had a recovery rate of 56 percent. The report also highlights the findings of an independent study conducted by the Office of Health Economics across nine GP practices in the Thames Valley, which found that Sleepio resulted in a projected saving of £106 per patient over three years. If Sleepio were made available across all clinical commissioning groups (CCGs) in England, this could represent savings for the NHS of as much as £56 million over three years.

CLINICAL STUDY

#cbt

View Analyst & Ambassador Comments
Go to original news
Aug 20,2020

Sleepio study suggests insomnia treatment could also improve depressive symptoms

The use of cognitive-behavioral therapy interventions, such as Big Health’s Sleepio program, has been found to improve both sleep and mental health in individuals with insomnia and clinically significant depressive symptoms, according to new research published in the Journal of Sleep Research. Although the study was conducted at the University of Oxford, some of the researchers have financial ties to Big Health, and parts of the investigation were funded by Big Health. The study included 3,352 participants as a sub-analysis of data collected from two randomized control trials measuring the effectiveness of Sleepio. Researchers found that addressing sleep problems in individuals who also have depressive symptoms could increase the resolution of depressive symptoms by up to three times.

CLINICAL STUDY

#cbt

View Analyst & Ambassador Comments
Go to original news
Aug 31,2020

Pear Therapeutics Announces Data from Two Studies Evaluating Somryst™ for Chronic Insomnia Presented at Virtual SLEEP 2020

Pear Therapeutics, Inc. announced findings today from two studies of an experimental precursor of Somryst™ (called SHUTi) that evaluated effectiveness to improve sleep outcomes and analyzed user journey data to predict intervention dropout, respectively. The current study evaluated 1,149 Australian adults aged 18-64 years with insomnia and depressive symptoms for the effectiveness of SHUTi vs. an attention-matched control with improving sleep outcomes measured by prospectively entered sleep diary data. Findings from a large-scale randomized controlled trial, Web-delivered CBT for Insomnia Intervention Improves Sleep Among Adults with Insomnia and Depressive Symptoms, show that Somryst can produce lasting improvements in sleep outcomes among adults with insomnia and elevated depressive symptoms.

CLINICAL STUDY

#pdt

#cbt

View Analyst & Ambassador Comments
Go to original news
Sep 09,2020

Orexo and GoGoMeds Partner to Bring Digital Therapies to Populations Battling Addiction and Depression with Limited Support Options

Orexo and GoGoMeds have formed a partnership to make the scientifically-proven, digital therapies deprexis® and vorvida® available for the treatment of depression and management of problematic alcohol misuse respectively. OXD01, a digital therapy for the treatment of opioid use disorders, will also be available in the US in Q4 2020 through the partnership. The partnership between Orexo and GoGoMeds will focus on making these solutions available through various complementary addiction services at the US state level, including court systems, as well as through private sector employers and other partners.

COLLABORATION PARTNERSHIP

#institution

#cbt

View Analyst & Ambassador Comments
Go to original news
Sep 09,2020

£1.3M TO SUPPORT MENTAL HEALTH SERVICES FOR ALL IN WALES

The package is supported by £1.3m Welsh Government funding and includes a new online Cognitive Behaviour Therapy course and other online and phone support services. NHS Wales and partners already provide some phone and online-based mental health support but today’s announcement will extend what is already available and provide a new online Cognitive Behavioural Therapy course, that anyone aged 16 or over can access. SilverCloud offers support for a range of issues including anxiety and depression. The national pilot of the programme is being evaluated to test usability and effectiveness, building on previous work led by Powys Local Health Board which so far has supported over 3,000 people.

COLLABORATION PARTNERSHIP

#institution

#cbt

View Analyst & Ambassador Comments
Go to original news
Sep 11,2020

Boehringer Ingelheim, Click Therapeutics ink $500M+ digital therapeutics development, commercialization deal

International pharma Boehringer Ingelheim and prescription digital therapeutics company Click Therapeutics have inked a $500 million-plus deal to jointly develop and commercialize a digital treatment for patients with schizophrenia. The treatment, referred to as CT-155, will be a mobile app built on Click's proprietary tech platform, the companies said. Employing cognitive and neurobehavioral mechanisms, it encourage patients to adjust their behavior with the ultimate aim of reducing their cognitive deficits and impaired social functioning. The companies intend for the final product to deliver these benefits when prescribed as a standalone treatment, or in combination with traditional pharmaceutical therapies.

COLLABORATION PARTNERSHIP

#r&d

#pdt

#cbt

View Analyst & Ambassador Comments
Go to original news
Sep 23,2020

PreferredOne Becomes First Health Plan to Cover Prescription Digital Therapeutics

Pear Therapeutics, Inc. and PreferredOne announced today that reSET® and reSET-O®, the first two prescription digital therapeutics (PDTs) to receive authorization to treat disease from the U.S. Food and Drug Administration (FDA), have been added to PreferredOne’s medical benefits as covered products for its members. PreferredOne is a wholly-owned subsidiary of Fairview Health Services, leads the market with products and services that conserve employer health plan dollars while helping more than 364,000 members achieve their best health.

COLLABORATION PARTNERSHIP

#insurance

#pdt

#cbt

View Analyst & Ambassador Comments
Go to original news
Sep 23,2020

Pear Therapeutics Announces Availability Of Reset® And Reset-O® To Wellpath Community Care Center Patients

Wellpath Community Care Centers and Pear Therapeutics, Inc. today announced availability of FDA-authorized prescription digital therapeutics (PDTs) with outpatient care, to elevate the nation’s battle against the substance and opioid use crisis. Wellpath Community Care Centers may now offer Pear’s reSET® and reSET-O® products to provide same day, single centered comprehensive medical and behavioral services with 24/7 access to optimize clinician delivered medication-assisted treatment (MAT) for optimal outcomes.

COLLABORATION PARTNERSHIP

#institution

#pdt

#cbt

View Analyst & Ambassador Comments
Go to original news
Sep 29,2020

Internet CBT for pediatric OCD maintains, or even increases, effectiveness over 12 months

New data suggest that an Internet-delivered cognitive behavioral therapy (ICBT) intervention not only remained effective after 12 months among adolescents with obsessive-compulsive disorder, but seemed to have an even greater impact on their symptoms with time. The average age of the 61 adolescents who received ICBT was about 14-and-a-half. The researchers found a significant increase in responses between the three-month and 12-month check-ins, with the latter having increased to a rate of 73%. The researchers saw a similar nine-month jump in remitters.

CLINICAL STUDY

#cbt

View Analyst & Ambassador Comments
Go to original news
Sep 30,2020

D.C. Housing Authority Offers Woebot to Employees and Residents

The District of Columbia Housing Authority (DCHA) today announced it has partnered with Woebot Health to offer Woebot, a smartphone-based general wellness program for stress and low mood, to all of DCHA’s 800 employees and to a pilot group of 450 residents living in the authority’s affordable housing communities. The pilot will be offered to residents of the Woodland Terrace and Greenleaf family communities and is expected to be rolled out to a broader group of residents in the future.

COLLABORATION PARTNERSHIP

#institution

#cbt

#mobile app

View Analyst & Ambassador Comments
Go to original news
Subscribe to CBT